Marianne Suwalski

Dr. Marianne Suwalski

Western University, London, Ontario, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ARAjay Rajaram
Ajay Rajaram
LYLawrence Yip
Lawrence Yip
Daniel MilejDaniel Milej
Daniel Milej
MSMarianne Suwalski
Marianne Suwalski
MKMatthew Kewin
Matthew Kewin
KLKeith St. Lawrence
Keith St. Lawrence
Post-hemorrhagic ventricular dilatation (PHVD) is characterized by a build-up of cerebral spinal fluid (CSF) in the ventricles, which increases intracranial pressure and compresses brain tissue. Clinical interventions (i.e., ventricular taps, VT) work to mitigate these complications through CSF drainage; however, the timing of these procedures remains imprecise. This study presents Neonatal NeuroMonitor (NNeMo), a portable optical device that combines broadband near-infrared spectroscopy (B-NIRS) and diffuse correlation spectroscopy (DCS) to provide simultaneous assessments of cerebral blood flow (CBF), tissue saturation (StO2), and the oxidation state of cytochrome c oxidase (oxCCO). In this study, NNeMo was used to monitor cerebral hemodynamics and metabolism in PHVD patients selected for a VT. Across multiple VTs in four patients, no significant changes were found in any of the three parameters: CBF increased by 14.6 ± 37.6% (p = 0.09), StO2 by 1.9 ± 4.9% (p = 0.2), and oxCCO by 0.4 ± 0.6 µM (p = 0.09). However, removing outliers resulted in significant, but small, increases in CBF (6.0 ± 7.7%) and oxCCO (0.1 ± 0.1 µM). The results of this study demonstrate NNeMo’s ability to provide safe, non-invasive measurements of cerebral perfusion and metabolism for neuromonitoring applications in the neonatal intensive care unit.

20 July 2022 in Neurophotonics
Verified
Journal Article
Open access
PDF file
Daniel MilejDaniel Milej
Daniel Milej
ARAjay Rajaram
Ajay Rajaram
MSMarianne Suwalski
Marianne Suwalski
LMLaura B. Morrison
Laura B. Morrison
LSLeena N. Shoemaker
Leena N. Shoemaker
KLKeith St. Lawrence
Keith St. Lawrence
The importance of adequate oxygen metabolism for maintaining cerebral health and function is well recognized considering the high energy demands of the brain—consuming 20% of the body’s total energy budget—and its reliance on blood flow for a constant supply of oxygen and glucose due to a lack of energy stores.1 Because of this dependency, inadequate oxygen delivery due to ischemia is a major cause of secondary brain injury in critical care patients recovering from life-threatening neurological emergencies, such as severe traumatic brain injury and subarachnoid hemorrhage.2,3 Independent of inadequate cerebral blood flow (CBF), another cause of secondary brain injury is mitochondrial dysfunction resulting from a hypoxic-ischemic insult. Mitochondrial dysfunction is also a major pathophysiological mechanism of neonatal encephalopathy and the neurologic sequela following cardiac arrest.4,5

31 August 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
MSMarianne Suwalski
Marianne Suwalski
LSLeena N. Shoemaker
Leena N. Shoemaker
JSJ. Kevin Shoemaker
J. Kevin Shoemaker
MDMamadou Diop
Mamadou Diop
JMJohn M. Murkin
John M. Murkin
Daniel MilejDaniel Milej
Daniel Milej
Near-infrared spectroscopy (NIRS) measurements of tissue oxygen saturation (StO2) are frequently used during vascular and cardiac surgeries as a non-invasive means of assessing brain health; however, signal contamination from extracerebral tissues remains a concern. As an alternative, hyperspectral (hs)NIRS can be used to measure changes in the oxidation state of cytochrome c oxidase (ΔoxCCO), which provides greater sensitivity to the brain given its higher mitochondrial concentration versus the scalp. The purpose of this study was to evaluate the depth sensitivity of the oxCCO signal to changes occurring in the brain and extracerebral tissue components. The oxCCO assessment was conducted using multi-distance hsNIRS (source-detector separations = 1 and 3 cm), and metabolic changes were compared to changes in StO2. Ten participants were monitored using an in-house system combining hsNIRS and diffuse correlation spectroscopy (DCS). Data were acquired during carotid compression (CC) to reduce blood flow and hypercapnia to increase flow. Reducing blood flow by CC resulted in a significant decrease in oxCCO measured at rSD = 3 cm but not at 1 cm. In contrast, significant changes in StO2 were found at both distances. Hypercapnia caused significant increases in StO2 and oxCCO at rSD = 3 cm, but not at 1 cm. Extracerebral contamination resulted in elevated StO2 but not oxCCO after hypercapnia, which was significantly reduced by applying regression analysis. This study demonstrated that oxCCO was less sensitive to extracerebral signals than StO2.